NCT03337347View on ClinicalTrials.gov

Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

January 1, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

October 23, 2015

Conditions
Colorectal CancerCirculating Tumor Cell
Interventions
DEVICE

CTC/DTC count

The presence of CTCs/DTCs in the peripheral blood and/or bone marrow may identify colorectal cancer patients with high risk of disease recurrence who may benefit from adjuvant therapy.

Trial Locations (1)

77900

University Hospital Olomouc, Olomouc

All Listed Sponsors
lead

The Institute of Molecular and Translational Medicine, Czech Republic

OTHER

NCT03337347 - Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients | Biotech Hunter | Biotech Hunter